Loading…

Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis...

Full description

Saved in:
Bibliographic Details
Published in:Malaria journal 2018-06, Vol.17 (1), p.243-243, Article 243
Main Authors: Henriques, Gisela, Phommasone, Koukeo, Tripura, Rupam, Peto, Thomas J, Raut, Shristi, Snethlage, Coco, Sambo, Im, Sanann, Nou, Nguon, Chea, Adhikari, Bipin, Pongvongsa, Tiengkham, Imwong, Mallika, von Seidlein, Lorenz, Day, Nicholas P, White, Nicholas J, Dondorp, Arjen M, Newton, Paul, Ley, Benedikt, Mayxay, Mayfong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323
cites cdi_FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323
container_end_page 243
container_issue 1
container_start_page 243
container_title Malaria journal
container_volume 17
creator Henriques, Gisela
Phommasone, Koukeo
Tripura, Rupam
Peto, Thomas J
Raut, Shristi
Snethlage, Coco
Sambo, Im
Sanann, Nou
Nguon, Chea
Adhikari, Bipin
Pongvongsa, Tiengkham
Imwong, Mallika
von Seidlein, Lorenz
Day, Nicholas P
White, Nicholas J
Dondorp, Arjen M
Newton, Paul
Ley, Benedikt
Mayxay, Mayfong
description Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis in G6PD deficient individuals and is, therefore, underused. Rapid diagnostic tests (RDTs) could permit ascertainment of G6PD status outside of laboratory settings and hence safe treatment in remote areas. The performance of the fluorescent spot test (Trinity, Ireland; FST) and a G6PD RDT (Carestart, USA) against spectrophotometry were assessed. Participants were enrolled during cross-sectional surveys in Laos and by purposive sampling in Cambodia. FST and RDT were performed during village surveys and 3 mL of venous blood was collected for subsequent G6PD measurement by spectrophotometry. A total of 757 participants were enrolled in Laos and 505 in Cambodia. FST and RDT performed best at 30% cut-off activity and performed significantly better in Laos than in Cambodia. When defining intermediate results as G6PD deficient, the FST had a sensitivity of 100% (95%CI 90-100) and specificity of 90% (95%CI 87.7-92.2) in Laos and sensitivity of 98% (94.1-99.6) and specificity of 71% (95%CI 66-76) in Cambodia (p 
doi_str_mv 10.1186/s12936-018-2390-6
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_fa3a92b2e20d453fa7dec8b584ad2758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A546902065</galeid><doaj_id>oai_doaj_org_article_fa3a92b2e20d453fa7dec8b584ad2758</doaj_id><sourcerecordid>A546902065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323</originalsourceid><addsrcrecordid>eNptks1u1DAUhSMEoqXwAGyQJTZsUmzHf9kgVUMLlUYCIVhbN7aT8SiJg51UmiVvjmemlA5CXtjy_e6x79EpitcEXxKixPtEaF2JEhNV0qrGpXhSnBMmeUmV5E8fnc-KFyltMSZSSfq8OKN1TWtO2HnxaxWGCaJPYUShRV2_mJBcKdC0CWnawOyQdZudjaFzIySH0gzzklCzQ22_hOiSceOM0hRmNLs0IxgtijB5i6yHbgxp9uZY8SNaQ0BfP347QCsYmpCZl8WzFvrkXt3vF8WPm-vvq8_l-sun29XVujRc4LnkjHHpiHVVw6RwlAlmFQPJ8owtUwRXVBowylQMQ8WNVKptBNimIYLlYnVR3B51bYCtnqIfIO50AK8PFyF2GmL-bO90CxXUtKGOYst41YK0zqiG5_cslVxlrQ9HrWlpBmf3FkToT0RPK6Pf6C7caYFJpQ4C7-4FYvi5ZHf04LOTfQ-jC0vSFHPFMeWCZfTtP-g2LHHMVmVKEkYVEeIv1UEewI9tyO-avai-4kzUmGLBM3X5Hyov6wZvwuhan-9PGsixwcSQUnTtw4wE630G9TGDOmdQ7zOo919589ich44_oat-A9J91tQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2071428166</pqid></control><display><type>article</type><title>Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Henriques, Gisela ; Phommasone, Koukeo ; Tripura, Rupam ; Peto, Thomas J ; Raut, Shristi ; Snethlage, Coco ; Sambo, Im ; Sanann, Nou ; Nguon, Chea ; Adhikari, Bipin ; Pongvongsa, Tiengkham ; Imwong, Mallika ; von Seidlein, Lorenz ; Day, Nicholas P ; White, Nicholas J ; Dondorp, Arjen M ; Newton, Paul ; Ley, Benedikt ; Mayxay, Mayfong</creator><creatorcontrib>Henriques, Gisela ; Phommasone, Koukeo ; Tripura, Rupam ; Peto, Thomas J ; Raut, Shristi ; Snethlage, Coco ; Sambo, Im ; Sanann, Nou ; Nguon, Chea ; Adhikari, Bipin ; Pongvongsa, Tiengkham ; Imwong, Mallika ; von Seidlein, Lorenz ; Day, Nicholas P ; White, Nicholas J ; Dondorp, Arjen M ; Newton, Paul ; Ley, Benedikt ; Mayxay, Mayfong</creatorcontrib><description>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis in G6PD deficient individuals and is, therefore, underused. Rapid diagnostic tests (RDTs) could permit ascertainment of G6PD status outside of laboratory settings and hence safe treatment in remote areas. The performance of the fluorescent spot test (Trinity, Ireland; FST) and a G6PD RDT (Carestart, USA) against spectrophotometry were assessed. Participants were enrolled during cross-sectional surveys in Laos and by purposive sampling in Cambodia. FST and RDT were performed during village surveys and 3 mL of venous blood was collected for subsequent G6PD measurement by spectrophotometry. A total of 757 participants were enrolled in Laos and 505 in Cambodia. FST and RDT performed best at 30% cut-off activity and performed significantly better in Laos than in Cambodia. When defining intermediate results as G6PD deficient, the FST had a sensitivity of 100% (95%CI 90-100) and specificity of 90% (95%CI 87.7-92.2) in Laos and sensitivity of 98% (94.1-99.6) and specificity of 71% (95%CI 66-76) in Cambodia (p &lt; 0.001). The RDT had sensitivity and specificity of 100% (95%CI 90-100) and 99% (95%CI 97-99) in Laos and sensitivity and specificity of 91% (86-96) and 93% (90-95) in Cambodia (p &lt; 0.001). The RDT performed significantly better (all p &lt; 0.05) than the FST when intermediate FST results were defined as G6PD deficient. The interpretation of RDT results requires some training but is a good alternative to the FST. Trial registration clinicaltrials.gov; NCT01872702; 06/27/2013; https://clinicaltrials.gov/ct2/show/NCT01872702.</description><identifier>ISSN: 1475-2875</identifier><identifier>EISSN: 1475-2875</identifier><identifier>DOI: 10.1186/s12936-018-2390-6</identifier><identifier>PMID: 29929514</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cambodia ; Care and treatment ; Child ; Child, Preschool ; Comparative analysis ; Dehydrogenase ; Dehydrogenases ; Diagnostic tests ; Diagnostic Tests, Routine - instrumentation ; Diagnostic Tests, Routine - methods ; Dosage and administration ; Dried Blood Spot Testing - instrumentation ; Dried Blood Spot Testing - methods ; Drug dosages ; Enzymes ; Female ; Fluorescent antibody technique ; Glucose ; Glucose-6-phosphate dehydrogenase ; Glucosephosphate dehydrogenase ; Glucosephosphate Dehydrogenase - analysis ; Glucosephosphate Dehydrogenase Deficiency - diagnosis ; Haemolysis ; Humans ; Laboratories ; Laos ; Malaria ; Male ; Medical screening ; Middle Aged ; Phosphates ; Plasmodium vivax ; Polls &amp; surveys ; Primaquine ; Rapid diagnostic test ; Sensitivity and Specificity ; Southeast Asia ; Specificity ; Spectrophotometry ; Surveys ; Training ; Young Adult</subject><ispartof>Malaria journal, 2018-06, Vol.17 (1), p.243-243, Article 243</ispartof><rights>COPYRIGHT 2018 BioMed Central Ltd.</rights><rights>Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323</citedby><cites>FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323</cites><orcidid>0000-0002-0282-6469</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013858/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2071428166?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29929514$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Henriques, Gisela</creatorcontrib><creatorcontrib>Phommasone, Koukeo</creatorcontrib><creatorcontrib>Tripura, Rupam</creatorcontrib><creatorcontrib>Peto, Thomas J</creatorcontrib><creatorcontrib>Raut, Shristi</creatorcontrib><creatorcontrib>Snethlage, Coco</creatorcontrib><creatorcontrib>Sambo, Im</creatorcontrib><creatorcontrib>Sanann, Nou</creatorcontrib><creatorcontrib>Nguon, Chea</creatorcontrib><creatorcontrib>Adhikari, Bipin</creatorcontrib><creatorcontrib>Pongvongsa, Tiengkham</creatorcontrib><creatorcontrib>Imwong, Mallika</creatorcontrib><creatorcontrib>von Seidlein, Lorenz</creatorcontrib><creatorcontrib>Day, Nicholas P</creatorcontrib><creatorcontrib>White, Nicholas J</creatorcontrib><creatorcontrib>Dondorp, Arjen M</creatorcontrib><creatorcontrib>Newton, Paul</creatorcontrib><creatorcontrib>Ley, Benedikt</creatorcontrib><creatorcontrib>Mayxay, Mayfong</creatorcontrib><title>Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia</title><title>Malaria journal</title><addtitle>Malar J</addtitle><description>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis in G6PD deficient individuals and is, therefore, underused. Rapid diagnostic tests (RDTs) could permit ascertainment of G6PD status outside of laboratory settings and hence safe treatment in remote areas. The performance of the fluorescent spot test (Trinity, Ireland; FST) and a G6PD RDT (Carestart, USA) against spectrophotometry were assessed. Participants were enrolled during cross-sectional surveys in Laos and by purposive sampling in Cambodia. FST and RDT were performed during village surveys and 3 mL of venous blood was collected for subsequent G6PD measurement by spectrophotometry. A total of 757 participants were enrolled in Laos and 505 in Cambodia. FST and RDT performed best at 30% cut-off activity and performed significantly better in Laos than in Cambodia. When defining intermediate results as G6PD deficient, the FST had a sensitivity of 100% (95%CI 90-100) and specificity of 90% (95%CI 87.7-92.2) in Laos and sensitivity of 98% (94.1-99.6) and specificity of 71% (95%CI 66-76) in Cambodia (p &lt; 0.001). The RDT had sensitivity and specificity of 100% (95%CI 90-100) and 99% (95%CI 97-99) in Laos and sensitivity and specificity of 91% (86-96) and 93% (90-95) in Cambodia (p &lt; 0.001). The RDT performed significantly better (all p &lt; 0.05) than the FST when intermediate FST results were defined as G6PD deficient. The interpretation of RDT results requires some training but is a good alternative to the FST. Trial registration clinicaltrials.gov; NCT01872702; 06/27/2013; https://clinicaltrials.gov/ct2/show/NCT01872702.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cambodia</subject><subject>Care and treatment</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Comparative analysis</subject><subject>Dehydrogenase</subject><subject>Dehydrogenases</subject><subject>Diagnostic tests</subject><subject>Diagnostic Tests, Routine - instrumentation</subject><subject>Diagnostic Tests, Routine - methods</subject><subject>Dosage and administration</subject><subject>Dried Blood Spot Testing - instrumentation</subject><subject>Dried Blood Spot Testing - methods</subject><subject>Drug dosages</subject><subject>Enzymes</subject><subject>Female</subject><subject>Fluorescent antibody technique</subject><subject>Glucose</subject><subject>Glucose-6-phosphate dehydrogenase</subject><subject>Glucosephosphate dehydrogenase</subject><subject>Glucosephosphate Dehydrogenase - analysis</subject><subject>Glucosephosphate Dehydrogenase Deficiency - diagnosis</subject><subject>Haemolysis</subject><subject>Humans</subject><subject>Laboratories</subject><subject>Laos</subject><subject>Malaria</subject><subject>Male</subject><subject>Medical screening</subject><subject>Middle Aged</subject><subject>Phosphates</subject><subject>Plasmodium vivax</subject><subject>Polls &amp; surveys</subject><subject>Primaquine</subject><subject>Rapid diagnostic test</subject><subject>Sensitivity and Specificity</subject><subject>Southeast Asia</subject><subject>Specificity</subject><subject>Spectrophotometry</subject><subject>Surveys</subject><subject>Training</subject><subject>Young Adult</subject><issn>1475-2875</issn><issn>1475-2875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks1u1DAUhSMEoqXwAGyQJTZsUmzHf9kgVUMLlUYCIVhbN7aT8SiJg51UmiVvjmemlA5CXtjy_e6x79EpitcEXxKixPtEaF2JEhNV0qrGpXhSnBMmeUmV5E8fnc-KFyltMSZSSfq8OKN1TWtO2HnxaxWGCaJPYUShRV2_mJBcKdC0CWnawOyQdZudjaFzIySH0gzzklCzQ22_hOiSceOM0hRmNLs0IxgtijB5i6yHbgxp9uZY8SNaQ0BfP347QCsYmpCZl8WzFvrkXt3vF8WPm-vvq8_l-sun29XVujRc4LnkjHHpiHVVw6RwlAlmFQPJ8owtUwRXVBowylQMQ8WNVKptBNimIYLlYnVR3B51bYCtnqIfIO50AK8PFyF2GmL-bO90CxXUtKGOYst41YK0zqiG5_cslVxlrQ9HrWlpBmf3FkToT0RPK6Pf6C7caYFJpQ4C7-4FYvi5ZHf04LOTfQ-jC0vSFHPFMeWCZfTtP-g2LHHMVmVKEkYVEeIv1UEewI9tyO-avai-4kzUmGLBM3X5Hyov6wZvwuhan-9PGsixwcSQUnTtw4wE630G9TGDOmdQ7zOo919589ich44_oat-A9J91tQ</recordid><startdate>20180622</startdate><enddate>20180622</enddate><creator>Henriques, Gisela</creator><creator>Phommasone, Koukeo</creator><creator>Tripura, Rupam</creator><creator>Peto, Thomas J</creator><creator>Raut, Shristi</creator><creator>Snethlage, Coco</creator><creator>Sambo, Im</creator><creator>Sanann, Nou</creator><creator>Nguon, Chea</creator><creator>Adhikari, Bipin</creator><creator>Pongvongsa, Tiengkham</creator><creator>Imwong, Mallika</creator><creator>von Seidlein, Lorenz</creator><creator>Day, Nicholas P</creator><creator>White, Nicholas J</creator><creator>Dondorp, Arjen M</creator><creator>Newton, Paul</creator><creator>Ley, Benedikt</creator><creator>Mayxay, Mayfong</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7SS</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>H95</scope><scope>H97</scope><scope>K9.</scope><scope>L.G</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0282-6469</orcidid></search><sort><creationdate>20180622</creationdate><title>Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia</title><author>Henriques, Gisela ; Phommasone, Koukeo ; Tripura, Rupam ; Peto, Thomas J ; Raut, Shristi ; Snethlage, Coco ; Sambo, Im ; Sanann, Nou ; Nguon, Chea ; Adhikari, Bipin ; Pongvongsa, Tiengkham ; Imwong, Mallika ; von Seidlein, Lorenz ; Day, Nicholas P ; White, Nicholas J ; Dondorp, Arjen M ; Newton, Paul ; Ley, Benedikt ; Mayxay, Mayfong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cambodia</topic><topic>Care and treatment</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Comparative analysis</topic><topic>Dehydrogenase</topic><topic>Dehydrogenases</topic><topic>Diagnostic tests</topic><topic>Diagnostic Tests, Routine - instrumentation</topic><topic>Diagnostic Tests, Routine - methods</topic><topic>Dosage and administration</topic><topic>Dried Blood Spot Testing - instrumentation</topic><topic>Dried Blood Spot Testing - methods</topic><topic>Drug dosages</topic><topic>Enzymes</topic><topic>Female</topic><topic>Fluorescent antibody technique</topic><topic>Glucose</topic><topic>Glucose-6-phosphate dehydrogenase</topic><topic>Glucosephosphate dehydrogenase</topic><topic>Glucosephosphate Dehydrogenase - analysis</topic><topic>Glucosephosphate Dehydrogenase Deficiency - diagnosis</topic><topic>Haemolysis</topic><topic>Humans</topic><topic>Laboratories</topic><topic>Laos</topic><topic>Malaria</topic><topic>Male</topic><topic>Medical screening</topic><topic>Middle Aged</topic><topic>Phosphates</topic><topic>Plasmodium vivax</topic><topic>Polls &amp; surveys</topic><topic>Primaquine</topic><topic>Rapid diagnostic test</topic><topic>Sensitivity and Specificity</topic><topic>Southeast Asia</topic><topic>Specificity</topic><topic>Spectrophotometry</topic><topic>Surveys</topic><topic>Training</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Henriques, Gisela</creatorcontrib><creatorcontrib>Phommasone, Koukeo</creatorcontrib><creatorcontrib>Tripura, Rupam</creatorcontrib><creatorcontrib>Peto, Thomas J</creatorcontrib><creatorcontrib>Raut, Shristi</creatorcontrib><creatorcontrib>Snethlage, Coco</creatorcontrib><creatorcontrib>Sambo, Im</creatorcontrib><creatorcontrib>Sanann, Nou</creatorcontrib><creatorcontrib>Nguon, Chea</creatorcontrib><creatorcontrib>Adhikari, Bipin</creatorcontrib><creatorcontrib>Pongvongsa, Tiengkham</creatorcontrib><creatorcontrib>Imwong, Mallika</creatorcontrib><creatorcontrib>von Seidlein, Lorenz</creatorcontrib><creatorcontrib>Day, Nicholas P</creatorcontrib><creatorcontrib>White, Nicholas J</creatorcontrib><creatorcontrib>Dondorp, Arjen M</creatorcontrib><creatorcontrib>Newton, Paul</creatorcontrib><creatorcontrib>Ley, Benedikt</creatorcontrib><creatorcontrib>Mayxay, Mayfong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (DOAJ)</collection><jtitle>Malaria journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Henriques, Gisela</au><au>Phommasone, Koukeo</au><au>Tripura, Rupam</au><au>Peto, Thomas J</au><au>Raut, Shristi</au><au>Snethlage, Coco</au><au>Sambo, Im</au><au>Sanann, Nou</au><au>Nguon, Chea</au><au>Adhikari, Bipin</au><au>Pongvongsa, Tiengkham</au><au>Imwong, Mallika</au><au>von Seidlein, Lorenz</au><au>Day, Nicholas P</au><au>White, Nicholas J</au><au>Dondorp, Arjen M</au><au>Newton, Paul</au><au>Ley, Benedikt</au><au>Mayxay, Mayfong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia</atitle><jtitle>Malaria journal</jtitle><addtitle>Malar J</addtitle><date>2018-06-22</date><risdate>2018</risdate><volume>17</volume><issue>1</issue><spage>243</spage><epage>243</epage><pages>243-243</pages><artnum>243</artnum><issn>1475-2875</issn><eissn>1475-2875</eissn><abstract>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis in G6PD deficient individuals and is, therefore, underused. Rapid diagnostic tests (RDTs) could permit ascertainment of G6PD status outside of laboratory settings and hence safe treatment in remote areas. The performance of the fluorescent spot test (Trinity, Ireland; FST) and a G6PD RDT (Carestart, USA) against spectrophotometry were assessed. Participants were enrolled during cross-sectional surveys in Laos and by purposive sampling in Cambodia. FST and RDT were performed during village surveys and 3 mL of venous blood was collected for subsequent G6PD measurement by spectrophotometry. A total of 757 participants were enrolled in Laos and 505 in Cambodia. FST and RDT performed best at 30% cut-off activity and performed significantly better in Laos than in Cambodia. When defining intermediate results as G6PD deficient, the FST had a sensitivity of 100% (95%CI 90-100) and specificity of 90% (95%CI 87.7-92.2) in Laos and sensitivity of 98% (94.1-99.6) and specificity of 71% (95%CI 66-76) in Cambodia (p &lt; 0.001). The RDT had sensitivity and specificity of 100% (95%CI 90-100) and 99% (95%CI 97-99) in Laos and sensitivity and specificity of 91% (86-96) and 93% (90-95) in Cambodia (p &lt; 0.001). The RDT performed significantly better (all p &lt; 0.05) than the FST when intermediate FST results were defined as G6PD deficient. The interpretation of RDT results requires some training but is a good alternative to the FST. Trial registration clinicaltrials.gov; NCT01872702; 06/27/2013; https://clinicaltrials.gov/ct2/show/NCT01872702.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>29929514</pmid><doi>10.1186/s12936-018-2390-6</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0282-6469</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1475-2875
ispartof Malaria journal, 2018-06, Vol.17 (1), p.243-243, Article 243
issn 1475-2875
1475-2875
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_fa3a92b2e20d453fa7dec8b584ad2758
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central
subjects Adolescent
Adult
Aged
Aged, 80 and over
Cambodia
Care and treatment
Child
Child, Preschool
Comparative analysis
Dehydrogenase
Dehydrogenases
Diagnostic tests
Diagnostic Tests, Routine - instrumentation
Diagnostic Tests, Routine - methods
Dosage and administration
Dried Blood Spot Testing - instrumentation
Dried Blood Spot Testing - methods
Drug dosages
Enzymes
Female
Fluorescent antibody technique
Glucose
Glucose-6-phosphate dehydrogenase
Glucosephosphate dehydrogenase
Glucosephosphate Dehydrogenase - analysis
Glucosephosphate Dehydrogenase Deficiency - diagnosis
Haemolysis
Humans
Laboratories
Laos
Malaria
Male
Medical screening
Middle Aged
Phosphates
Plasmodium vivax
Polls & surveys
Primaquine
Rapid diagnostic test
Sensitivity and Specificity
Southeast Asia
Specificity
Spectrophotometry
Surveys
Training
Young Adult
title Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A16%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20glucose-6%20phosphate%20dehydrogenase%20status%20by%20fluorescent%20spot%20test%20and%20rapid%20diagnostic%20test%20in%20Lao%20PDR%20and%20Cambodia&rft.jtitle=Malaria%20journal&rft.au=Henriques,%20Gisela&rft.date=2018-06-22&rft.volume=17&rft.issue=1&rft.spage=243&rft.epage=243&rft.pages=243-243&rft.artnum=243&rft.issn=1475-2875&rft.eissn=1475-2875&rft_id=info:doi/10.1186/s12936-018-2390-6&rft_dat=%3Cgale_doaj_%3EA546902065%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2071428166&rft_id=info:pmid/29929514&rft_galeid=A546902065&rfr_iscdi=true